Skip to main content
Swing Capital

Krishna Institute of Medical Sciences Ltd

NSE: KIMS BSE: 543308Healthcare

Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.

₹723
52W: ₹576 — ₹798
PE 109 · Book ₹60.7 · +1091% vs book
Market Cap₹28,934 Cr
Stock P/E109Price to Earnings
ROCE12.8%Return on Capital
ROE11.6%Return on Equity
Div. Yield0%Face Value ₹2

Weaknesses

  • −Stock is trading at 12.2 times its book value
  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −Company has a low return on equity of 12.9% over last 3 years.
  • −Promoter holding has decreased over last 3 years: -4.73%

Shareholding Pattern

Promoters34.11%
FIIs14.57%
DIIs32.5%
Public18.82%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters38.82%38.82%38.82%38.82%34.11%▼4.734.11%34.11%34.11%
FIIs17.84%15.85%▼2.015.68%▼0.215.44%▼0.215.54%▲0.115.03%▼0.514.33%▼0.714.57%▲0.2
DIIs32.12%32.29%▲0.232.05%▼0.231.95%▼0.131.65%▼0.332.12%▲0.532.72%▲0.632.5%▼0.2
Public11.22%13.03%▲1.813.45%▲0.413.78%▲0.318.68%▲4.918.74%▲0.118.85%▲0.118.82%▼0.0

Financial Statements

MetricDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales302305327363348346373430442456
Expenses215218234252245237276318314326
Operating Profit87869411110310998112128130
OPM %29%28%29%31%30%31%26%26%29%29%
Net Profit58486172769459647266
EPS ₹1.461.21.521.81.912.341.471.591.811.65

AI Insights

Revenue Trend

Mar 2026 revenue at ₹1,702Cr, up 23% YoY. OPM at 28%.

Debt Position

Borrowings at ₹1,526Cr. Debt-to-equity ratio: 0.65x. Moderate leverage.

Capex Cycle

CWIP at ₹116Cr (8% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 32.5% (-3.27pp change). FIIs: 14.57% (+1.42pp change). Promoters hold 34.11%.

Margin & Efficiency

ROCE improving from 0% (Mar 2016) to 13% (Mar 2026). Working capital days: -35.

Valuation

PE 109x with 12.8% ROCE. Price is 1091% above book value of ₹60.7. Dividend yield: 0%.

Recent Announcements